Cover Image

Cardioprotective Agents for the Primary Prevention of Trastuzumab-Associated Cardiotoxicity: A Systematic Review and Meta-Analysis

There are significant considerations about the prevention of cardiotoxicity caused by trastuzumab therapy in patients with breast cancer, leading to discontinuation. Recently, randomized controlled trials (RCTs) have evaluated the effects of early commitment of beta-blockers (BBs), angiotensin recep...

Full description

Saved in:

Bibliographic Details
Main Authors:	Kyriakos Goulas (Author), Dimitrios Farmakis (Author), Anastasia Constantinidou (Author), Nikolaos P. E. Kadoglou (Author)
Format:	Book
Published:	MDPI AG, 2023-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Pharmaceutical Prevention and Management of Cardiotoxicity in Hematological Malignancies
by: Anastasia Stella Perpinia, et al.
Published: (2022)

Cardioprotective potential of botanical agents against anthracycline-induced cardiotoxicity
by: Parisa Firoozbakhsh, et al.
Published: (2024)

Cardiotoxicity and Cardioprotection by Artesunate in Larval Zebrafish
by: Chuanrui Zheng, et al.
Published: (2020)

Therapeutic Potentials of Selected Antihypertensive Agents and Their Fixed-Dose Combinations Against Trastuzumab-Mediated Cardiotoxicity
by: Olufunke Esan Olorundare, et al.
Published: (2021)

Interventions for Preventing Cardiotoxicity in Breast Cancer Patients Receiving Trastuzumab: A Systemic Review and Bayesian Network Meta-Analysis
by: Xinyi Li, et al.
Published: (2021)

Antioxidant Protection against Trastuzumab Cardiotoxicity in Breast Cancer Therapy
by: Gabriel Méndez-Valdés, et al.
Published: (2023)

Cardioprotective Strategies for Doxorubicin-induced Cardiotoxicity: Present and Future
by: A. M. Chaulin, et al.
Published: (2022)

Cardioprotective Roles of β-Hydroxybutyrate Against Doxorubicin Induced Cardiotoxicity
by: Yihai Liu, et al.
Published: (2021)

The Impact of Chemotherapy on Arterial Stiffness and Ventricular-Arterial Coupling in Women with Breast Cancer
by: Nikolaos P. E. Kadoglou, et al.
Published: (2024)

Doxorubicin cardiotoxicity and Camellia sinensis cardioprotection determined by speckle-tracking echocardiography
by: Maira Souza Oliveira Barreto, et al.
Published: (2023)

Cardioprotective effect of vanillic acid against doxorubicin-induced cardiotoxicity in rat
by: Bahar Baniahmad, et al.
Published: (2020)

Histopathological Study on The Effect of Neuregulin-1 Against Cardiotoxicity Induced By Trastuzumab in Adult Mice
by: yousuf gays majeed, et al.
Published: (2018)

Cardioprotective effects of sodium thiosulfate against doxorubicin-induced cardiotoxicity in male rats
by: Maryam Shekari, et al.
Published: (2022)

Mechanism of the Cardioprotective Effects of Docetaxel Pre-administration Against Adriamycin-Induced Cardiotoxicity
by: Mari Tomonari, et al.
Published: (2011)

Antioxidant and cardioprotective activity of Stachys schimperi Vatke against doxorubicin-induced cardiotoxicity
by: Essam Abdel-Sattar, et al.
Published: (2012)

Cardioncological Approach for Trastuzumab Therapy in Breast Cancer Patients With Cardiotoxicity: Impact on Adherence and Clinical Outcome
by: Iacopo Fabiani, et al.
Published: (2020)

The Cardioprotective Mechanism of Phenylaminoethyl Selenides (PAESe) Against Doxorubicin-Induced Cardiotoxicity Involves Frataxin
by: Xiaoyu Fu, et al.
Published: (2021)

Aerobic Exercise Training as a Potential Cardioprotective Strategy to Attenuate Doxorubicin-Induced Cardiotoxicity
by: Samir A. Kouzi, et al.
Published: (2016)

Biomarker panel for early screening of trastuzumab -induced cardiotoxicity among breast cancer patients in west virginia
by: Sneha S. Pillai, et al.
Published: (2022)

Editorial of the Special Issue Titled "Drug Candidates for the Prevention and Treatment of Cardiovascular Diseases"
by: Nikolaos P. E. Kadoglou
Published: (2024)

Acetylcholinesterase inhibition protects against trastuzumab-induced cardiotoxicity through reducing multiple programmed cell death pathways
by: Thawatchai Khuanjing, et al.
Published: (2023)

Human Pluripotent Stem Cells for Modeling of Anticancer Therapy-Induced Cardiotoxicity and Cardioprotective Drug Discovery
by: Wendy Keung, et al.
Published: (2021)

The cardioprotective properties of Persicaria maculosa and Citrus sinensis extracts against doxorubicin-induced cardiotoxicity in mice
by: Mohammad Zaki, et al.
Published: (2024)

Isosteviol: A potential cardioprotective agent
by: Jovanović Aleksandar
Published: (2024)

Beta-blockers for the primary prevention of anthracycline-induced cardiotoxicity: a meta-analysis of randomized controlled trials
by: Yingxu Ma, et al.
Published: (2019)

Risk factors associated with trastuzumab-induced cardiotoxicity in patients with human epidermal growth factor receptor 2-positive breast cancer
by: Wesam Abdel-Razaq, et al.
Published: (2019)

Phytochemical profiling and cardioprotective activity of Vernonia amygdalina ethanol extract (VAEE) against ISO-induced cardiotoxicity in rats
by: Arya Tjipta Prananda, et al.
Published: (2023)

Methyl Palmitate: the Naturally Occurring Cardioprotective Agent
by: Ahmed Hamed, et al.
Published: (2020)

Liraglutide attenuates gefitinib-induced cardiotoxicity and promotes cardioprotection through the regulation of MAPK/NF-κB signaling pathways
by: Abdullah F. AlAsmari, et al.
Published: (2020)

Risk of hepatotoxicity with trastuzumab emtansine in breast cancer patients: a systematic review and meta-analysis
by: Amani M. Cobert, et al.
Published: (2020)

Use of trastuzumab in treating breast cancer during pregnancy: a systematic review and meta-analysis
by: Lin-Yu Xia, et al.
Published: (2021)

Genetic testing in psychiatry, the perceptions of healthcare workers and patients: a mini review
by: Kyriakos I. Ioannou, et al.
Published: (2024)

Cardioprotective effects of Rhododendron arboreum leaf extract against Doxorubicin-induced cardiotoxicity in Wistar rats by modulating electrocardiographic and cardiac biomarkers
by: Adersikha Pradhan, et al.
Published: (2023)

Combination of Panax ginseng C. A. Mey and Febuxostat Boasted Cardioprotective Effects Against Doxorubicin-Induced Acute Cardiotoxicity in Rats
by: Hayder M. Al-Kuraishy, et al.
Published: (2022)

Assessment of survival and cardiotoxicity of adjuvant trastuzumab among HER2 breast cancer patients in an oncology centre in Malaysia / Harissa H Hasbullah ... [et al.]
by: Hasbullah, Harissa H, et al.
Published: (2018)

Modeling Cardiotoxicity in Pediatric Oncology Patients Using Patient-Specific iPSC-Derived Cardiomyocytes Reveals Downregulation of Cardioprotective microRNAs
by: Ignacio Reinal, et al.
Published: (2023)

Cardiotoxicity of doxorubicin - causes, prevention, prospects
by: Paweł Wesołowski, et al.
Published: (2022)

Effect of shenmai injection on anthracycline-induced cardiotoxicity: A systematic review and meta-analysis
by: Lili Yang, et al.
Published: (2024)

Cardioprotective and hypotensive mechanistic insights of hydroethanolic extract of Cucumis melo L. kernels in isoprenaline-induced cardiotoxicity based on metabolomics and in silico electrophysiological models
by: Muqeet Wahid, et al.
Published: (2024)

Prevalence of Cardioprotective Medication Use in Coronary Heart Disease Patients in South America: Systematic review and Meta-Analysis
by: A. Marzà-Florensa, et al.
Published: (2022)